Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences

Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis

(2012) Carol Aristimuño et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients

(2011) Benedikt Fritzsching et al.   PLoS One

Human regulatory T cells in autoimmune diseases

(2010) Gregory L Cvetanovich et al.   CURRENT OPINION IN IMMUNOLOGY

Estradiol-dependent perforin expression by human regulatory T-cells

(2010) Larissa Valor et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes

(2010) Alexandre Boissonnas et al.   IMMUNITY

Gender-Associated Differences of Perforin Polymorphisms in the Susceptibility to Multiple Sclerosis

(2010) M. Camina-Tato et al.   JOURNAL OF IMMUNOLOGY

Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis

(2010) Tara Beeston et al.   JOURNAL OF NEUROIMMUNOLOGY

IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study

(2009) Carol Aristimuño et al.   CLINICAL IMMUNOLOGY

Sexual Dimorphism in Autoimmune Disease

(2009) P. McCombe et al.   CURRENT MOLECULAR MEDICINE

Variations of the perforin gene in patients with multiple sclerosis

(2008) G Cappellano et al.   GENES AND IMMUNITY

Resurgence or emergence of CD8+ Ts

(2008) George Vlad et al.   HUMAN IMMUNOLOGY

Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse

(2008) C ARISTIMUNO et al.   JOURNAL OF NEUROIMMUNOLOGY

Compromised CD4+ CD25highregulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level

(2007) Koen Venken et al.   IMMUNOLOGY